Characterisation of adipocyte-derived extracellular vesicles released pre- and post-adipogenesis by Connolly, Katherine D. et al.
ORIGINAL RESEARCH ARTICLE
Characterisation of adipocyte-derived extracellular
vesicles released pre- and post-adipogenesis
Katherine D. Connolly1, Irina A. Guschina2, Vincent Yeung3, Aled Clayton3,
Mohd Shazli Draman1, Christopher Von Ruhland4, Marian Ludgate1,
Philip E. James5 and D. Aled Rees1*
1Institute of Molecular and Experimental Medicine, School of Medicine, Cardiff University, Cardiff,
United Kingdom; 2School of Biosciences, Cardiff University, Cardiff, United Kingdom; 3Institute of
Cancer Genetics, School of Medicine, Velindre Cancer Centre, Cardiff University, Cardiff, United Kingdom;
4Central Biotechnology Services, School of Medicine, Cardiff University, Cardiff, United Kingdom; 5School of
Health Sciences, Cardiff Metropolitan University, Cardiff, United Kingdom
Extracellular vesicles (EVs) are submicron vesicles released from many cell types, including adipocytes. EVs are
implicated in the pathogenesis of obesity-driven cardiovascular disease, although the characteristics of
adipocyte-derived EVs are not well described. We sought to define the characteristics of adipocyte-derived EVs
before and after adipogenesis, hypothesising that adipogenesis would affect EV structure, molecular
composition and function. Using 3T3-L1 cells, EVs were harvested at day 0 and day 15 of differentiation.
EV and cell preparations were visualised by electron microscopy and EVs quantified by nanoparticle tracking
analysis (NTA). EVs were then assessed for annexin V positivity using flow cytometry; lipid and phospholipid
composition using 2D thin layer chromatography and gas chromatography; and vesicular protein content by an
immuno-phenotyping assay. Pre-adipogenic cells are connected via a network of protrusions and EVs at both
time points display classic EV morphology. EV concentration is elevated prior to adipogenesis, particularly in
exosomes and small microvesicles. Parent cells contain higher proportions of phosphatidylserine (PS) and show
higher annexin V binding. Both cells and EVs contain an increased proportion of arachidonic acid at day 0.
PREF-1 was increased at day 0 whilst adiponectin was higher at day 15 indicating EV protein content reflects
the stage of adipogenesis of the cell. Our data suggest that EV production is higher in cells before adipogenesis,
particularly in vesicles B300 nm. Cells at this time point possess a greater proportion of PS (required for EV
generation) whilst corresponding EVs are enriched in signalling fatty acids, such as arachidonic acid, and
markers of adipogenesis, such as PREF-1 and PPARg.
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A
dipose tissue is no longer regarded as simply an
inert store of excess energy, but as an endocrine
organ that can secrete a variety of adipokines and
signalling entities that promote interaction with other cell
types proximally, such as endothelial cells and fibroblasts,
and distally, such as cells of the central nervous system (1).
In addition to these soluble factors, adipocytes have
also been shown to release extracellular vesicles (EVs)
in vitro (24). EVs are classically defined as submicron
vesicles released into the external environment of the cell.
This allows subsequent isolation of EVs from biological
fluids, most commonly plasma, urine and the conditioned
media of cultured cells (5). EVs are known to carry a
specific cargo of mRNA, microRNA, proteins and lipids
that may be transferred to target cells through mecha-
nisms which are not fully defined (6).
EVs comprise exosomes, microvesicles and apoptotic
bodies. The latter are typically larger (15 mm) vesicles
released from cells prior to apoptosis (7) and are con-
sequently excluded from the description of EVs hence-
forth. Exosomes, which typically range in size from 30 to
100 nm, are generated within multivesicular endosomal

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compartments.These may then fuse with the plasma
membrane to release exosomes via exocytosis as part
of the cell’s homeostatic recycling mechanism (8,9). Micro-
vesicles are formed as a consequence of localised disruption
of the cytoskeleton and normal phospholipid asymmetry,
resulting in exposure of phosphatidylserine (PS); commonly
used to identify microvesicle populations via annexin V
binding (10). Microvesicles, whose sizes range from 100 to
1 mm, bud directly from the plasma membrane and hence
often carry surface antigens from the cell of origin (11).
Despite the importance of adiposity as a major risk
factor for cardiovascular disease and the emerging evi-
dence of a pathogenic role for EVs in a number of cardio-
vascular diseases (12), very little is known about the
characteristics of adipocyte-derived EVs. Studies in rat
primary adipocyte cultures have shown these EVs can
interact locally with neighbouring adipocytes to promote
lipid esterification and that their release is upregulated by
both physiological (e.g. insulin) and pharmacological (e.g.
glimepiride) stimuli (4). The murine adipocyte cell line
3T3-L1 has also been reported to produce EVs containing
adipokines (2,3) and factors that promote angiogenesis
in vivo (13). Human adipose tissue explants have also been
shown to produce EVs that can modulate monocyte
differentiation and alter insulin signalling in adipocytes
(14) and liver cells (15). These findings suggest that EVs
may represent an additional mechanism by which adipocytes
communicate with neighbouring and distant cell types.
However, adipocyte-derived EVs are not well characterised;
hence, we sought to define EV production, structure and
content in 3T3-L1 cells, before and after adipogenesis.
Methods
Cell culture
3T3-L1 cells were cultured using T175 cm2 flasks
(Cellstar†, Greiner Bio-One, Germany) in ‘‘control media’’
containing a 1:1 ratio of DMEM (high glucose, 4.5 g/L):
F12 supplemented with 10% foetal calf serum and 1%
penicillin/streptomycin (Gibco†, Life Technologies, UK).
At confluence, serum-free control medium was added for
24 hours for subsequent EV isolation (day 0). Control
medium was then supplemented with inducers of differ-
entiation (Sigma Aldrich, UK): insulin (10 mg/mL),
indomethacin (50 mM) and dexamethasone (1 mM) and
added to cells for 2 days. Cells were then maintained in
control medium supplemented with insulin (10 mg/mL) for
the remainder of their maturation. Fourteen days after
induction of differentiation, serum-free control medium
(with 10 mg/mL insulin) was added for 24 hours for
subsequent EV isolation (day 15).
Cell counts were undertaken at both time points (day 0
and day 15) using trypan blue and a cellometer automatic
cell counter (Nexcelom Bioscience, MA, USA). Adipo-
genesis was confirmed using oil red O staining and western
blot analysis of total cell lysates (10 mg) for the preadipo-
cyte factor-1 (PREF-1) and the mature adipocyte markers
adiponectin and fatty acid binding protein 4 (FABP4)
(Supplementary Fig. 1).
EV isolation
EVs were isolated from conditioned serum-free media to
avoid EV contamination from foetal calf serum (Supple-
mentary Fig. 2). Medium was collected at day 0 and day
15 to analyse EVs from immature and mature adipocytes,
respectively.
Following collection, conditioned medium was imme-
diately centrifuged at 1,000g for 5 minutes to remove
any cells in suspension. The supernatant was then cen-
trifuged at 15,000g for 15 minutes at 48C to remove any
cell debris. Finally, supernatants were ultracentrifuged at
100,000g for 1 hour at 48C to pellet EVs. EV pellets were
then resuspended in 1 sterile PBS for subsequent
analysis. EVs for flow cytometry were resuspended in
1 sterile annexin V binding buffer (BD Biosciences, CA)
to allow staining for annexin V. For all parameters, EVs
were stored at 48C and utilised within 1 week of isolation.
All buffers used to resuspend EV samples had been 0.22
mm-filtered.
Electron microscopy
Cells at both day 0 and day 15 were washed in PBS and
fixed in gluteraldehyde-PBS (1%, v/v) at room temperature
for 1 hour. Cells were then stored in PBS at 48C until
processing for scanning electron microscopy (SEM). SEM
samples were dehydrated through graded propan-1-ol (50,
70, 90, and 2100% for 10 minutes each) followed by
three exchanges in hexamethyldisilazane. Samples were
then air dried and splutter-coated with gold and viewed at
5 kV in a JEOL 840 SEM (JEOL, Tokyo, Japan).
EVs were isolated in PBS from cells at each time point as
above and stored at 48C for transmission electron micro-
scopy (TEM). EVs were negatively stained as follows by
placing grids onto 50 mL droplet of reagent. Vesicles were
adsorbed onto formvar-carbon coated grids (20 minutes)
and fixed in glutaraldehyde (1%, v/v) for 10 minutes at
room temperature. Grids were then washed (31 minute
in PBS and 61 minute in water) before negative staining
with 2% (w/v) uranyl acetate for 10 minutes. Surplus
stain was shaken off grids and allowed to air dry before
being examined in a Philips CM12 TEM (FEI UK Ltd.)
at 80 kV.
EV size and concentration analysis
Size and concentration distributions of EVs were deter-
mined using nanoparticle tracking analysis (NTA). Briefly,
NTA uses the light scattering properties and Brownian
motion of laser-illuminated particles in suspension to de-
termine EV size and concentration. NTA was undertaken
using the NanoSight LM10 configured with a 642 nm laser
(NanoSight Ltd., UK) using NTA software version 2.3.
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Camera shutter speed was maintained at 30.01 ms and
camera gain to 500. Samples were diluted in EV-free sterile
water (Fresenius Kabi, UK) to concentrations between
2108 and 1109 particles/mL. Sixty-second videos were
recorded in replicates of 5 per sample with camera
sensitivity and detection threshold set to between 1315
and 45, respectively. Temperature was monitored manu-
ally and ranged from 22 to 268C. EV concentrations and
distributions were then normalised to the cell count for the
respective time point and expressed as EVs/viable cell.
Annexin V positivity
Annexin V positivity is one suggested characteristic of
microvesicles, therefore we sought to characterise the
Annexin V positivity of adipocyte EVs and their cell of
origin. 3T3-L1 cells in 1PBS (0.22-mm-filtered) were
analysed using a BD FACSCanto (BD Biosciences, CA) as
an unstained control. Cells were then pelleted and resus-
pended in 1 annexin V binding buffer and incubated in
the dark at room temperature for 15 minutes with annexin
V-FITC (Biolegend, CA). Following staining, cells were
pelleted and resuspended in 1PBS and analysed for their
annexin V positivity.
EVs were analysed directly by flow cytometry, without
the use of beads. Unstained EVs (in 1X annexin V buffer)
were used as negative controls. EVs were then stained with
annexin V-FITC (as above) and analysed.
Data were exported from the FACSDivaTM software
(version 6) and subsequently analysed using FlowJo soft-
ware (version 10; Tree Star Inc., OR).
Analysis of fatty acids
Gas chromatography with flame ionisation detection (GC-
FID) was used to determine fatty acid concentration and
composition as previously described (16). Lipid extraction
from cells and EVs in PBS (entire amounts of cells/EVs
from T175 cm2 flasks) in replicates of 6 was undertaken
using chloroform:methanol ( 1:2, v/v) by the method of
Garbus et al. (17). Fatty acid methyl esters (FAMEs) were
then generated and analysed using GC, as previously
described (18). Fatty acid quantification was performed by
addition of a known amount of C17:0 (heptadecanoic
acid, Nu-Chek Prep Inc., Elysian, MN) as an internal
standard. FAMEs were identified by comparison of their
retention times with those of standards (N-15-A, Nu-Chek
Prep Inc., Elysian, MN; Supelco 37 Component FAME
Mix, Sigma Aldrich, UK). Total Chrom Navigator soft-
ware (Perkin Elmer) was used for data acquisition. A list
of individual fatty acids is presented in Supplementary
Table I.
Phospholipid separation and quantification
Cells and EVs from both time points were isolated and
lipids were extracted (as above) from pooled samples (from
7T175 cm2 flasks) to ensure enough material for thin-
layer chromatography (TLC) separation. Phospholipids
were separated using two-dimensional TLC using 1010
cm boric impregnated (1.2% boric acid in ethanol/water
1:1 (v/v)) silica gel 60 plates (Sigma Aldrich, UK). Phos-
pholipids were separated using chloroform:methanol:
ammonium hydroxide (65:35:10, v/v/v) in the first dimen-
sion and then N-butanol:acetic acid:deionised water
(90:20:20, v/v/v) in the second. The plates were then dried
completely and sprayed with a 0.05% (v/v) solution of
8-anilino-4-napthosulphonic acid in dry methanol in order
to visualise individual phospholipids under UV light. Indi-
vidual phospholipids were scraped from the plates and
their fatty acids were converted into FAMEs (as described
before) for GC analysis and phospholipid quantification.
EV protein content
EVs at day 0 and day 15 were probed for exosomal and
adipocyte markers using high protein binding ELISA
plates (Greiner Bio-One, Germany). Protein concentration
of EV samples was determined using a PierceTM BCA
Protein Assay Kit (Thermo Scientific, UK) and 1 mg of EV
sample was loaded into each well. EVs were allowed to
settle overnight before a buffer (RIPA Lysis Buffer System;
Santa Cruz, CA, USA) was added to permeabilise EVs for
analysis of intravesicular EV and adipocyte markers.
Exosomal markers included rabbit anti-mouse CD9,
CD63, tumour susceptibility gene 101 (TSG101) (Santa
Cruz) and mouse anti-mouse alix (Cell Signaling Tech-
nologies, New England BioLabs, UK). Adipocyte markers
included rabbit anti-mouse FABP4, peroxisome proliferator-
activated receptor g (PPARg), adiponectin and preadi-
pocytes factor-1 (PREF-1) (Cell Signaling Technologies).
Markers were detected using anti-mouse or anti-rabbit
biotin-labelled secondary antibodies (Perkin Elmer) and
a streptavidineuropium conjugate (Perkin Elmer) and
analysed using time resolved fluorescence (Wallac Victor2
1420 plate reader, Perkin Elmer; and FLUOstar OPTIMA
microplate reader, BMG Labtech, UK).
Statistical analysis
Data are presented as mean9SD. An unpaired Student’s
t-test or a one- or two-way ANOVA were used to analyse
differences between means. Analyses were conducted using
GraphPad Prism (version 6; GraphPad Software Inc.,
CA), p-values B0.05 were considered significant.
Results
Electron microscopy
Cells at day 0 appeared to be connected by a network of
protrusions between multiple cells whilst cells at day 15
were much larger and rounder with a number of vacuole-
like structures (Fig. 1A and B, respectively). EVs at both
time points displayed polydispersity in size and a classic
‘‘cup-like’’ morphology (Fig. 1C and D).
Adipocyte-derived EVs released in adipogenesis
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EV size and concentration
Viable cell counts are shown in Supplementary Fig. 3. EV
production was higher at day 0 compared to day 15 (992.79
226.2 versus 276.59104.8 EVs/viable cell, respectively,
pB0.0001, Fig. 2A) though mode size of EVs did not
change between the two time points (135.498.9 to 137.19
7.6 nm, p0.6), Fig. 2B). The EV size/concentration
distribution showed that this elevation at day 0 was
observable across the whole EV spectrum, particularly in
EVs B300 nm (Fig. 2C).
Cell and EV annexin V positivity
Figure 3 illustrates the gates used to analyse cells (A) and
EVs (B) for annexin V positivity. Annexin V positivity fell
in both cells (2.191.7 to 0.490.2%, p0.04) and non-
significantly in EVs (6.396.6 to 2.992.2%, p0.3) from
day 0 to day 15; overall, annexin V positivity was higher in
EVs than in cells (Fig. 3C/D).
Fatty acid concentration and composition of cells
and EVs
Total fatty acid concentration of cells and EVs increased
from day 0 to day 15 (cells: 0.190.04 to 0.790.2 mg/106
cells, pB0.0001, Fig. 4A and EVs: 12.291.7 to 27.39
10.1 ng/106 EVs, p0.005, Fig. 4C). Individual fatty acid
compositions were expressed as a change from day 0 to day
15. Out of 25 fatty acids identified, 18 were different in cells
and 17 in EVs between day 0 and day 15 (Fig. 4B and D,
respectively). The majority of fatty acids reduced in
proportion (of the total) with differentiation in cells and
EVs. For example, arachidonic acid (C20:4n6) was re-
duced in both cells and EVs following differentiation.
Many fatty acids were affected by differentiation in the
same way; however, the effect was sometimes unique to the
cell or EV. For example, the amount of oleic acid (C18:1n9)
was decreased in cells but increased in EVs from day 0 to
day 15. Certain fatty acids were also unique to the stage of
differentiation, for example, eicosatrienoic acid (C20:3n3)
was only present at day 0 in cells and EVs. Compositions of
fatty acids were also different between cells and their
corresponding EVs at each time point (Supplementary
Table II).
Phospholipid composition
Proportions of phospholipids were different between cells
and EVs from day 0 to day 15 (Fig. 5). Phosphatidylcho-
line (PC) was the most abundant phospholipid present at
both time points in cells and EVs. PC content showed a
Fig. 1. Electron microscopy of 3T3-L1 cells and corresponding EVs pre- and post-differentiation. Scanning electron microscopy images
of 3T3-L1 cells at day 0 (A) and day 15 (B). Transmission electron microscopy images of 3T3-L1 EVs at day 0 (C) and day 15 (D). Note
scale bars differ between images and types of electron microscopy.
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slight increase with differentiation in cells; in contrast, PC
was higher in EVs prior to differentiation. The propor-
tion of phosphatidylethanolamine (PE) appeared to
increase with differentiation in both cells and EVs
whereas both phosphatidylinositol (PI) and sphingomye-
lin decreased with differentiation in cells, but showed an
increase over the same time in EVs. Cells and EVs had
higher proportions of PS at day 0 compared with day 15.
Cardiolipin was only present in cells and showed an
increase from day 0 to day 15.
EV protein content
No differences were observed in EVexosomal markers and
PPARg from day 0 to day 15 (Fig. 6). FABP4 and PREF-1
decreased (108,25697,460 to 93,08894,804, p0.002 for
FABP4; and 86,958918,164 to 58,91897,485 arbitrary
TRF units, p0.006 for PREF-1, respectively) while
adiponectin increased (76,242911,501 to 161,886930,
371 arbitrary TRF units, pB0.0001) with differentiation
in EVs.
Discussion
Adipose tissue is now known to provide more than basic
insulation, structural support and lipid storage properties.
It is recognised as an endocrine organ that can influence a
number of physiological processes through interaction
with a variety of tissues, primarily via adipokine secretion
(19). More recently adipocytes have been shown in vitro to
release EVs (24, 1315), providing an additional poten-
tial mechanism of communication for adipocytes. Here we
present a detailed characterisation of adipocyte-derived
EVs with respect to: structure and morphology; size and
Fig. 2. Effect of differentiation on EV size and concentration. The effect of 3T3-L1 differentiation on: EV production per viable cell
(A); mode EV size (B); and EV size distribution (C). ****pB0.0001, n6 (day 0) and n5 (day 15).
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concentration; annexin V positivity; fatty acid profile;
phospholipid composition; and protein content pre- and
post-differentiation.
The evidence for adipocyte EVs acting as paracrine and
endocrine communicators is continually growing. For
example, Kranendonk et al. recently found EVs from
different adipose tissue depots enhance monocyte to
macrophage differentiation and affect insulin signalling
in hepatocytes (14,15). However, to our knowledge there
are no data which report on their size and concentration
distributions. We found that EV production per cell
was greater at the preadipocyte stage particularly in EVs
B300 nm. This may be a consequence (or a cause) of the
differentiation process such that EVs act as intercellular
communicators to promote transition to a mature adipo-
cyte. This is also supported by the scanning electron
micrograph images which show long and numerous
projections between cells at day 0, suggesting a local
communication network between cells prior to differentia-
tion. Conversely, as anticipated, mature adipocytes at day
15 were much larger and independent of each other, with
individual cells containing multiple lipid vacuoles.
Many studies support the principle that release of EVs
follows a disruption of the plasma membrane asymmetry
of the cell and subsequent exposure of PS. However, it is
debated whether this externalised PS is retained on the
EV (20,21). We sought to characterise the PS positivity of
adipocyte EVs and their corresponding cells by measur-
ing their annexin V positivity. Cells and EVs at both day
0 and day 15 showed relatively low annexin V positivity
(B10%); lower than reported for plasma-derived EVs
which typically possess between 50 and 90% annexin V
positivity (18,22,23). However, the majority of plasma
EVs are derived from platelets and can promote coagula-
tion due to their high density of PS exposure (corre-
sponding with high annexin V binding) (24). It is unlikely
that adipocyte-derived EVs would be pro-coagulant
perhaps explaining their low annexin V positivity.
Much of the research surrounding EVs focuses on the
concentration and/or surface antigens of EVs, and how
changes in these characteristics may modulate a change in
function. Little is known about the lipid composition of
EVs, despite lipids being recognised as important com-
ponents of many signalling pathways. We therefore used
Fig. 3. Cell and EV Annexin V positivity. The effect of differentiation on 3T3-L1 and EV Annexin V positivity. (A) shows the gate used
to analyse 3T3-L1 cells, (B) shows the gate used to analyse 3T3-L1-derived EVs and (C) shows the Annexin V-FITC positivity of cells
and EVs on day 0 and day 15 of differentiation (n6, except day 15 EVs where n5) *pB0.05.
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GC-FID to comprehensively characterise the lipid com-
position of the 3T3-L1 cells and their corresponding EVs
pre- and post-differentiation. As expected, total lipid
concentration increased with adipogenesis in cells. Inter-
estingly, this too was reflected in the EV fraction, again
highlighting a characteristic of the cell of origin that is
maintained in the EV. Proportions of individual fatty acids
were clearly altered in both cells and EVs with differentia-
tion which likely reflects the transition in function from a
preadipocyte to a mature adipocyte. For instance, we
observed a large increase in palmitic acid (C16:0), the most
abundant storage fatty acid in animals (25), with differ-
entiation of cells and hence accumulation of lipid. The
effect of differentiation was also reflected in the presence
or lack of certain fatty acids at each time point. For ex-
ample, eicosatrienoic acid (C20:3n3) was present at day 0
but not at day 15. This polyunsaturated fatty acid is found
in poorly vascularised tissues where abundance of free
fatty acids is low (26). This loss of eicosatrienoic acid may
reflect the transition to a mature adipocyte where con-
centrations of free fatty acids are higher so it is no longer
required. Additionally, the proportion of arachidonic acid
(C20:4n6), a major precursor for many cell signalling
molecules, was much higher in cells and EVs at day 0 than
those at day 15. Taken together with the elevated EV
concentration at day 0, this supports the notion that
increased EV production in preadipocytes is a conse-
quence and perhaps a communicator of increased signal-
ling in the early stages of differentiation. In keeping with
this, exosome isolates from human adipose-derived stem
cells (hASCs) undergoing adipogenic differentiation have
been reported to assist undifferentiated hASCs to transi-
tion towards a mature adipocyte (27). Furthermore, a
higher proportion of phospholipids associated with cell
signalling, such as PS and PI, were present at the day 0 time
point in cells. PS in particular is heavily implicated in EV
generation (8,28). Here EV generation was greater at day 0,
when, in cells the proportion of PS was 3 X greater than
cells at day 15, suggesting an increased reserve of PS to
generate EVs at this time point. In the EV fraction, the
proportion of PS showed only a slight decrease with
differentiation, suggesting that cells require a higher pro-
portion of PS for the formation of EVs but that this PS is
not necessarily incorporated into the EVs. Finally, when
Fig. 4. Cell and EV fatty acid concentration and change in composition. Total fatty acid concentration of 3T3-L1 cells and EVs at day 0
and day 15 of differentiation (A and C, respectively). Changes in proportions of individual fatty acids in cells and EVs between day 0 and
day 15 of differentiation (B and D, respectively). ****pB0.0001, ***pB0.001, **pB0.01, *pB0.05, n6 (day 0) and n5 (day 15).
Adipocyte-derived EVs released in adipogenesis
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comparing the composition of fatty acids between cells
and their corresponding EVs at each time point (Supple-
mentary Table II), EVs were shown to be enriched in
certain fatty acids that their cells were not. Future work
should look to classify these changes in more detail and to
analyse whether these differences harbour potential func-
tional implications for EVs. We have previously observed
similar differences between fatty acid compositions of
plasma and plasma-derived EVs (18,22), suggesting that
although EVs reflect their cell of origin in many aspects,
they also possess unique characteristics which may affect
how they communicate and interact with other cells.
Functional changes in protein expression can also occur
within the vesicle following stimulation or stress of the
parental cell (29). Flow cytometry is limited to analysing
surface antigens of EVs meaning these important altera-
tions are not typically identified. Moreover, due to the low
refractive index of EVs, conventional flow cytometers have
a lower detection limit of 200 nm, meaning 65% of
3T3-L1 EVs would not be detected. Here, we used an in-
house developed immuno-phenotyping assay (previously
described (30)), used successfully by others in the EV field
to analyse both membrane and intravesicular proteins
(31). Levels of typical exosomal proteins showed no
change with differentiation. Alix, a cytosolic protein
associated with endocytic membrane trafficking (32)
gave the highest signal of the exosomal markers. This
suggests that although the number of EVs is elevated at
Fig. 5. Phospholipid composition of cells and EVs following differentiation. Proportions and labelled percentages of phospholipids in:
cells at day 0 (A); and day 15 (B), and EVs at day 0 (C); and day 15 (D) n1. PEphosphatidylethanolamine; PCphosphatidylcholine;
PSphosphatidylserine; PIphosphatidylinositol.
Fig. 6. Effect of differentiation on EV protein content. The
content of vesicular (CD9, CD63, TSG101 and Alix) and
adipocyte (FABP4, PREF-1, adiponectin and PPARg) proteins
in 3T3-L1 derived EVs before and following differentiation.
Proteins were detected using a streptavidineuropium conju-
gate and measured using TRF (arbitrary units) **pB0.01,
****pB0.0001, n3.
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day 0, the relative expression of exosomal proteins within
each EV does not change between the time points. We
selected 4 well-established adipocyte markers known to be
prevalent at different stages of adipogenesis to analyse
within EVs (33,34). PPARg is a nuclear receptor required
for the induction (including the growth arrest of cells (33))
and maintenance of adipogenesis (34). Here, EV PPARg
content showed no difference between day 0 and day 15
suggesting that PPARg produced by cells during growth
arrest at day 0 and by cells maintaining differentiation at
day 15 is also passed into corresponding EVs. Levels of
PREF-1 and adiponectin in EVs also seem to reflect the
stage of differentiation of the cell. PREF-1 is an EGF-like
protein that represses differentiation, promoting a pre-
adipocyte phenotype (35). Here PREF-1 decreased from
day 0 to day 15, in keeping with progression to a mature
adipocyte phenotype. Conversely, adiponectin, a major
adipokine produced by mature adipocytes (36) increased
in EVs with differentiation as the cells mature and
accumulate lipid. Interestingly, FABP4, a cytoplasmic
fatty acid trafficking protein (37) decreased in EVs with
differentiation. FABP4 is a dominant protein in mature
adipocytes, accounting for 1% of the total cytosolic
fraction (38). This again indicates that EVs do not always
reflect their cell of origin.
There are currently a number of issues surrounding
standardisation of protocols in the EV field, meaning
preparatory techniques are constantly being updated.
Here differential centrifugation was employed to isolate
vesicles as described previously (13). Interim centrifuga-
tion speeds between 10,000 and 20,000g have been
recently reported to pellet some larger microvesicles (39).
Therefore a limitation of this study may be the use of a
15,000g spin which may have pelleted larger microvesi-
cles as well as cell debris and apoptotic bodies. However, a
range of EVs up to 1 mm are still detectable (Fig. 2C)
indicating larger microvesicles are still present. Serum-free
media was used for the conditioning time for EV isolation:
24 hours prior to day 0 and day 15 (Supplementary Fig. 2).
The requirements of the cells are different at these two
stages hence serum-free media was supplemented with
insulin prior to day 15, whereas media for day 0 was not.
This was to minimise changes to normal media at each time
point components but we do acknowledge this may have
affected EVrelease at day 15. A further limitation is the use
of a cell line for characterisation, although 3T3-L1 cells are
widely used as a reliable model to study adipocyte biology
(40). Other groups have successfully isolated EVs from
primary adipocyte sources and have similarly found the
presence of adipocyte and exosomal markers within
adipocyte EVs (14,15,41). Flow cytometry to assess EV
annexin V positivity was conducted on EVs directly. Many
conventional flow cytometers have a practical lower limit
of 200 nm, meaning many smaller microvesicles and
exosomes will not be detected by this method. Therefore,
the annexin V positivity of the EVs may have been
underestimated here, particularly if a proportion of larger
microvesicles (known to have a greater annexin V positivity)
were removed by the 15,000g spin. To ensure capture of
the whole EV spectrum, future studies should use bead-
based capture of EVs with flow cytometry or an alternative
method to asses EV annexin V positivity.
In summary, the production of adipocyte-derived EVs is
significantly affected by differentiation. Prior to adipogen-
esis, the production of EVs enriched in pro-signalling fatty
acids is high, suggesting that EVs may aid communication
between preadipocytes to enhance the transition to a
mature adipocyte. Adipocyte-derived EVs possess many
similar characteristics of their cell of origin such as low
annexin V positivity and similar lipid content. However,
adipocyte-derived EVs may also possess unique qualities
that confer different functional properties such as a dif-
ferential fatty acid composition that change with the stage
of differentiation. Future studies will explore the func-
tional impact of adipocyte EVs on the control of adipo-
genesis and their wider implications in cardiovascular
disease.
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